Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd
Bullboard Posts
User Avatar Image
(38)
•••
Comment by cloinveston Apr 09, 2019 11:49am
86 Views
Post# 29602185

RE:RE:Rent and Salary

RE:RE:Rent and Salary
Crazydavid wrote:
Traidsman wrote: I am new to this board but am invested with around 200k shares. I have a personal history with this property since it was kraft and before they purchased the property. I am very sceptical and am getting very concerned as even if they do have 50 mil in the bank of their own money the property tax and utilities to run that property as well as the salaries they are paying out will chew through that in less than 2 years time and that was from the inception of the purchase before axly came on board almost a year ago. the product they are producing doesn't even come close to negating the cost of the the building and salary let alone the buildout. I am only stating the facts as i know them. My investment is at an ave of .34 so i have abit in but have played the highs and lows since the day they came on. They have no viable product line and a few investments in other properties and businesses. I have heard nothing about FSD Jamaica since they said the bought it. I am seriously considering cutting my losses with this and just moving the remainder to Cannera. They have facilities and products to be sold. I would appreciate any thoughts or feedback on this.




 




fsd has a part in Cannara so if Cannara does well so will fsd.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities